Screening of Antimicrobial Agents for In Vitro Radiation Protection and Mitigation Capacity, Including those Used in Supportive Care Regimens for Bone Marrow Transplant Recipients

Similar Items

• Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca(−/−)) Mice
  od: Sivananthan, Aranee, i dr.
  Izdano: (2018)
• Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Ιs Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350
  od: EPPERLY, MICHAEL W, i dr.
  Izdano: (2017)
• Effects of the Bifunctional Sulfoxide MMS350, a Radiation Mitigator, on Hematopoiesis in Long-term Bone Marrow Cultures and on Radioresistance of Marrow Stromal Cell Lines
  od: SHINDE, ASHWIN, i dr.
  Izdano: (2014)
• Amelioration of Radiation-Induced Pulmonary Fibrosis by a Water-Soluble Bifunctional Sulfoxide Radiation Mitigator (MMS350)
  od: Kalash, Ronny, i dr.
  Izdano: (2013)
• Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039
  od: EPPERLY, MICHAEL W., i dr.
  Izdano: (2020)